StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
9
Publishing Date
2023 - 09 - 20
1
2023 - 05 - 02
1
2021 - 12 - 14
1
2021 - 12 - 07
1
2021 - 07 - 27
1
2021 - 06 - 23
1
2021 - 04 - 21
1
2021 - 01 - 06
2
Sector
Health technology
9
Tags
Alliances
3
Antibody
7
Authorization
3
Authorized
3
Biotech
40
Biotech-bay
16
Biotechnology
4
Business
4
Care
4
Chronic hepatitis b
9
Collaboration
4
Conference
10
Covid
18
Covid-19
4
Ema
4
Emergency use authorization
4
Fda
3
Financial
13
Financial results
5
Global
5
Health
3
Hepatitis
26
Hiv
3
Infection
3
Infections
5
Influenza
6
Injection
4
Iot
29
Liver
10
Market
4
Meeting
5
Merge
3
N/a
89
Ongoing
4
People
4
Phase 1
4
Phase 2
10
Phase 3
4
Platform
3
Positive
6
Potential
5
Pre-clinical
5
Preclinical
5
Presentation
4
Report
8
Research
5
Results
23
Risk
3
Sars-cov-2
8
Technology
27
Therapeutics
3
Treatment
16
Trial
17
Update
14
Vaccine
9
Vir-2218
5
Vir-2482
3
Vir-3434
3
Virus
4
Year
3
Entities
Alnylam pharmaceuticals, inc.
1
Glaxosmithkline plc
2
Johnson & johnson
1
Redhill biopharma ltd.
1
Sanofi
1
Sorrento therapeutics, inc.
1
Vbi vaccines, inc.
2
Vir biotechnology, inc.
9
Xencor, inc.
1
Symbols
ABT
10
ACIU
10
AGEN
13
ALPMF
7
ALPMY
7
AMRS
8
ANIX
24
APDN
9
ARCT
18
ARVL
31
AZN
29
AZNCF
19
BNTX
111
BWV
20
CMXHF
7
CNC
8
CSLLY
7
CVAC
25
CVS
12
DVAX
82
DYAI
17
EBS
15
EVAX
17
FNCTF
34
GLAXF
35
GOVX
32
GRTS
23
GSK
56
IBRX
10
ICVX
7
INO
22
JNJ
327
LLY
8
MRK
20
MRNA
142
NRXP
11
NVAX
132
NVS
16
NVSEF
10
OCGN
25
ORMP
11
PAHC
9
PCVX
10
PDSB
9
PFE
106
SNGX
12
SNY
258
SNYNF
163
SRNE
8
STRO
9
TAK
27
TMO
8
TNXP
26
TSN
8
VAXX
9
VBIV
64
VCNX
34
VIR
9
VXRT
44
ZTS
9
Exchanges
Nasdaq
9
Nyse
2
Crawled Date
2023 - 09 - 20
1
2023 - 05 - 02
1
2021 - 12 - 14
1
2021 - 12 - 07
1
2021 - 07 - 27
1
2021 - 06 - 23
1
2021 - 04 - 21
1
2021 - 01 - 06
2
Crawled Time
11:00
2
12:00
2
13:00
1
13:03
1
14:00
1
18:00
1
23:00
1
Source
www.biospace.com
1
www.globenewswire.com
4
www.prnewswire.com
2
www.vbivaccines.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Vaccine
symbols :
Vir
save search
Vir Biotechnology Announces First Participant Dosed in New Phase 1 Trial Evaluating VIR-1388, an Investigational T Cell Vaccine for the Prevention of HIV
Published:
2023-09-20
(Crawled : 12:00)
- globenewswire.com
VIR
|
$8.02
0.75%
140K
|
Health Technology
|
-16.24%
|
O:
-0.3%
H:
0.61%
C:
-4.58%
vir-1388
vaccine
cell
hiv
Vir Biotechnology Receives Expanded Support to Develop Its Novel T Cell Vaccine Platform with New $10 Million Grant for HIV Prevention
Published:
2023-05-02
(Crawled : 13:00)
- globenewswire.com
VIR
|
$8.02
0.75%
140K
|
Health Technology
|
-67.21%
|
O:
-0.6%
H:
0.52%
C:
-1.56%
vaccine
cell
grant
hiv
platform
Preclinical Data Highlight the Significant Antigenic Shift of the Omicron SARS-CoV-2 Variant and its Effect on the Neutralizing Activity of Monoclonal Antibodies, Convalescent Antibodies and Vaccine-Elicited Antibodies
Published:
2021-12-14
(Crawled : 23:00)
- globenewswire.com
XNCR
|
$18.65
-1.58%
130K
|
Health Technology
|
-43.48%
|
O:
3.02%
H:
6.19%
C:
5.15%
VIR
|
$8.02
0.75%
140K
|
Health Technology
|
-82.08%
|
O:
6.71%
H:
10.12%
C:
5.09%
monoclonal antibodies
preclinical
sars-cov-2
vaccine
antibody
pre-clinical
Anxious World Waits As Covid Vaccine Makers Address Omicron Variant
Published:
2021-12-07
(Crawled : 14:00)
- prnewswire.com
GLAXF
|
$20.2
510
|
Health Technology
|
0.4%
|
O:
5.22%
H:
0.0%
C:
-1.25%
JNJ
|
News
|
$146.39
0.45%
1.8M
|
Health Technology
|
-9.67%
|
O:
2.13%
H:
0.0%
C:
0.0%
GSK
|
$39.685
1.06%
380K
|
Health Technology
|
-5.42%
|
O:
0.14%
H:
0.0%
C:
0.0%
VIR
|
$8.02
0.75%
140K
|
Health Technology
|
-80.52%
|
O:
-6.42%
H:
8.6%
C:
8.45%
SRNE
|
$0.024
57K
|
Health Technology
|
-99.6%
|
O:
6.57%
H:
14.77%
C:
11.21%
RDHL
|
$0.425
1.0%
120K
|
Health Technology
|
-85.5%
|
O:
0.37%
H:
10.37%
C:
9.63%
covid
vaccine
Global $9.5 Billion Influenza Vaccines Market to 2027
Published:
2021-07-27
(Crawled : 11:00)
- prnewswire.com
GSK
|
$39.685
1.06%
380K
|
Health Technology
|
1.49%
|
O:
0.41%
H:
1.0%
C:
0.87%
VIR
|
$8.02
0.75%
140K
|
Health Technology
|
-77.68%
|
O:
-0.68%
H:
2.23%
C:
-0.76%
SNY
|
News
|
$46.34
2.09%
620K
|
Health Technology
|
-11.85%
|
O:
-0.54%
H:
0.65%
C:
0.49%
vaccine
influenza
Brii Biosciences and VBI Vaccines Present Positive Data from Completed Phase 1b/2a Study on BRII-179 (VBI-2601) in Patients with Chronic Hepatitis B at the International Liver Congress 2021
Published:
2021-06-23
(Crawled : 11:00)
- vbivaccines.com
VIR
|
$8.02
0.75%
140K
|
Health Technology
|
-82.69%
|
O:
-0.34%
H:
2.23%
C:
-0.86%
VBIV
|
$0.639
1.48%
43K
|
Health Technology
|
-83.8%
|
O:
1.03%
H:
1.53%
C:
-0.76%
hepatitis
phase 1
positive
vbi-2601
vaccine
liver
phase 1b
phase 2b
chronic hepatitis b
Brii Biosciences, Vir Biotechnology, and VBI Vaccines Announce Initiation of Phase 2 Clinical Trial of BRII-835 (VIR-2218) in Combination with BRII-179 (VBI-2601) for the Treatment of Hepatitis B
Published:
2021-04-21
(Crawled : 12:00)
- vbivaccines.com
VIR
|
$8.02
0.75%
140K
|
Health Technology
|
-82.98%
|
O:
-1.09%
H:
0.38%
C:
0.04%
VBIV
|
$0.639
1.48%
43K
|
Health Technology
|
-75.86%
|
O:
0.0%
H:
7.66%
C:
7.66%
ALNY
|
News
|
$146.34
0.81%
64K
|
Health Technology
|
6.71%
|
O:
0.67%
H:
1.12%
C:
0.43%
treatment
phase 2
hepatitis
vbi-2601
biotech
vaccine
technology
iot
brii-835
trial
Vir Biotechnology Announces Initiation of Phase 1 Clinical Trial to Evaluate a Novel Vaccine Platform– Culmination of a decade-long collaboration with Oregon Health & Science University and the Bill & Melinda Gates Foundation –
Published:
2021-01-06
(Crawled : 18:00)
- biospace.com/
VIR
|
$8.02
0.75%
140K
|
Health Technology
|
-68.68%
|
O:
-0.57%
H:
4.54%
C:
1.26%
collaboration
biotech
vaccine
trial
phase 3
phase 1
phase 2
decades
Vir Biotechnology Announces Initiation of Phase 1 Clinical Trial to Evaluate a Novel Vaccine Platform
Published:
2021-01-06
(Crawled : 13:03)
- globenewswire.com
VIR
|
$8.02
0.75%
140K
|
Health Technology
|
-68.68%
|
O:
-0.57%
H:
4.54%
C:
1.26%
biotech
vaccine
trial
phase 3
phase 1
phase 2
platform
Gainers vs Losers
79%
21%
Top 10 Gainers
AGBA
|
News
|
$1.22
205.0%
86M
|
Finance
EGOX
|
$0.0606
68.33%
250M
|
NVFY
|
$3.45
63.51%
20M
|
Consumer Durables
ZCMD
|
$1.98
36.55%
27M
|
Commercial Services
CHRO
|
$1.66
35.51%
70K
|
n/a
INDO
|
$5.43
33.09%
10M
|
Energy Minerals
PAPL
|
$2.07
26.22%
550K
|
RWOD
|
$10.08
26.05%
5.6M
|
n/a
AULT
|
$0.304
25.57%
47M
|
Manufacturing
HUSA
4
|
$2.07
23.95%
2.1M
|
Energy Minerals
Your saved searches
Save your searches and get alerts when important news are released.